Pages that link to "Q28283418"
Jump to navigation
Jump to search
The following pages link to Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action (Q28283418):
Displaying 50 items.
- F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia. (Q24564963) (← links)
- F15063, a potential antipsychotic with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. I. In vitro receptor affinity and efficacy profile (Q24564964) (← links)
- d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology. (Q28067851) (← links)
- Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT(1A) receptors but not 5-HT(2A) receptors (Q28273285) (← links)
- Multifunctional Pharmacology of Flibanserin: Possible Mechanism of Therapeutic Action in Hypoactive Sexual Desire Disorder (Q28293268) (← links)
- Exploring the role of 5-HT1A receptors in the regulation of prepulse inhibition in mice: implications for cross-species comparisons (Q30444307) (← links)
- Consequences of post-weaning social isolation on anxiety behavior and related neural circuits in rodents. (Q30487008) (← links)
- Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission (Q30493133) (← links)
- Serotonin, inhibition, and negative mood (Q33318080) (← links)
- Emotional decision-making and its dissociable components in schizophrenia and schizoaffective disorder: a behavioural and MRI investigation (Q33754259) (← links)
- In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat. (Q34238841) (← links)
- Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research. (Q34350194) (← links)
- Cognitive effects of second-generation antipsychotics: current insights into neurochemical mechanisms. (Q34609271) (← links)
- Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): actions at serotonin receptors may enhance downstream release of four pro-cognitive neurotransmitters (Q34670569) (← links)
- Effects of 5-HT drugs in prefrontal cortex during memory formation and the ketamine amnesia-model (Q34788049) (← links)
- Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat (Q35179053) (← links)
- Effect of dopaminergic D1 receptors on plasticity is dependent of serotoninergic 5-HT1A receptors in L5-pyramidal neurons of the prefrontal cortex. (Q35182442) (← links)
- Reduced cholesterol is associated with the depressive-like behavior in rats through modulation of the brain 5-HT1A receptor (Q35226076) (← links)
- The cytochrome P450 2D-mediated formation of serotonin from 5-methoxytryptamine in the brain in vivo: a microdialysis study (Q35541620) (← links)
- Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment (Q36382946) (← links)
- Rethinking 5-HT1A receptors: emerging modes of inhibitory feedback of relevance to emotion-related behavior (Q36540897) (← links)
- Serotonin modulation of cortical neurons and networks (Q36778507) (← links)
- Glucocorticoid Receptors, Brain-Derived Neurotrophic Factor, Serotonin and Dopamine Neurotransmission are Associated with Interferon-Induced Depression (Q36852421) (← links)
- HTR1A Polymorphisms and Clinical Efficacy of Antipsychotic Drug Treatment in Schizophrenia: A Meta-Analysis (Q36950578) (← links)
- Comodulation of dopamine and serotonin on prefrontal cortical rhythms: a theoretical study (Q37068729) (← links)
- Long-Term Citalopram Treatment Alters the Stress Responses of the Cortical Dopamine and Noradrenaline Systems: the Role of Cortical 5-HT1A Receptors (Q37220477) (← links)
- Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology (Q37224949) (← links)
- Neural basis for the ability of atypical antipsychotic drugs to improve cognition in schizophrenia (Q37231628) (← links)
- Catecholamine/Serotonin interactions: systems thinking for brain function and disease (Q37518766) (← links)
- Therapeutic Role of 5-HT1A Receptors in The Treatment of Schizophrenia and Parkinson's Disease (Q37811038) (← links)
- Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models. (Q37954123) (← links)
- The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar mania. (Q38057380) (← links)
- Pharmacogenetics of clinical response to risperidone. (Q38074712) (← links)
- Disruption of thalamocortical activity in schizophrenia models: relevance to antipsychotic drug action (Q38117750) (← links)
- Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia (Q38149953) (← links)
- The role of serotonin in memory: interactions with neurotransmitters and downstream signaling (Q38178842) (← links)
- Psychopharmacology of atypical antipsychotic drugs: From the receptor binding profile to neuroprotection and neurogenesis (Q38258215) (← links)
- How semantic deficits in schizotypy help understand language and thought disorders in schizophrenia: a systematic and integrative review (Q38429406) (← links)
- Clozapine effects on adenylyl cyclase activity and serotonin type 1A receptors in human brain post-mortem (Q39271592) (← links)
- A systematic investigation of the differential roles for ventral tegmentum serotonin 1- and 2-type receptors on food intake in the rat. (Q39587382) (← links)
- Clozapine functions through the prefrontal cortex serotonin 1A receptor to heighten neuronal activity via calmodulin kinase II-NMDA receptor interactions. (Q40226041) (← links)
- Clozapine Reverses Phencyclidine-Induced Desynchronization of Prefrontal Cortex through a 5-HT(1A) Receptor-Dependent Mechanism. (Q40494872) (← links)
- Development of CNS multi-receptor ligands: Modification of known D2 pharmacophores (Q40626733) (← links)
- Successful treatment with risperidone increases 5-HT 3A receptor gene expression in patients with paranoid schizophrenia - data from a prospective study. (Q41691255) (← links)
- Preferential in vivo action of F15599, a novel 5-HT(1A) receptor agonist, at postsynaptic 5-HT(1A) receptors. (Q41967962) (← links)
- Expression of Serotonin2C Receptors in Pyramidal and GABAergic Neurons of Rat Prefrontal Cortex: A Comparison with Striatum (Q42494096) (← links)
- Prefrontal cortex lesions cause only minor effects on the hyperlocomotion induced by MK-801 and its reversal by clozapine (Q42644512) (← links)
- Neuronal apoptosis and reversible motor deficit in dominant-negative GSK-3 conditional transgenic mice. (Q42751805) (← links)
- Characterization of the electrophysiological properties of triple reuptake inhibitors on monoaminergic neurons (Q43165318) (← links)
- COMT and 5-HT1A-receptor genotypes potentially affect executive functions improvement after cognitive remediation in schizophrenia. (Q43170052) (← links)